Stocks to Keep Your Eyes on: Haemonetics Corporation (NYSE:HAE) & Penn Virginia Corporation (NASDAQ:PVAC)

5

Haemonetics Corporation (NYSE:HAE)

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn’t need one and provides the right blood product, at the right time, in the right dose to the right patient who does.

Haemonetics Corporation (NYSE:HAE)’s Financial Overview

Haemonetics Corporation (NYSE) surged 1.49% yesterday to close its trading session at $85.31. The company has 1 year Price Target of $123.33. Haemonetics Corporation has 52-Week high of $117.56 and 52-Week Low of $68.14. The stock touched its 52-Week High on 117.56 and 52-Week Low on 68.14. The stock traded with the volume of 441150 shares yesterday. The firm shows the market capitalization of $4.44 Billion.

Haemonetics Corporation (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.56/share against the analyst consensus estimate of $0.54/share. The difference between the actual and expected EPS is $0.02 a share with a surprise factor of 3.7%.

The firm is trading with SMA20 of -9.75 Percent, SMA50 of -13.1 Percent and SMA200 of -14.25 percent. Haemonetics Corporation has P/S value of 4.67 while its P/B value stands at 6.82. Similarly, the company has Return on Assets of 3.7 percent, Return on Equity of 6.6 percent and Return on Investment of 7.7 Percent. The company shows Gross Margin and Operating Margin of 45.4 percent and 7.8 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 6 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 125.00, with a high estimate of 135.00 and a low estimate of 108.00. The median estimate represents a +46.52% increase from the last price of 85.31.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Penn Virginia Corporation (NASDAQ:PVAC)

Penn Virginia Corporation is an oil and gas company. It engaged in exploration, development and production of oil, NGLs and natural gas. The company operates primarily in Eagle Ford Shale in South Texas and Oklahoma. Penn Virginia Corporation is headquatered in Houston, Texas.

Penn Virginia Corporation (NASDAQ:PVAC)’s Financial Outlook

The 2 analysts offering 12-month price forecasts for Penn Virginia Corp have a median target of 68.00, with a high estimate of 79.00 and a low estimate of 57.00. The median estimate represents a +29.70% increase from the last price of 52.43.

Penn Virginia Corporation is expected* to report earnings on 02/27/2019 before market open. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $3.8. The reported EPS for the same quarter last year was $1.06.

According to Zacks Investment Research, Penn Virginia Corporation has a Consensus Recommendation of 2. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock surged 4.36% and closed its last trading session at $52.43. The company has the market capitalization of $796.94 Million. The stock has 52-week high of $96.13 and 52-Week low of $32.49. The firm touched its 52-Week high on 96.13 and 52-Week low on 32.49. The company has volume of 105493 shares. The company has a total of 15.2 Million shares outstanding.

Penn Virginia Corporation (NASDAQ) in the last quarter reported its actual EPS of $2.72/share where the analyst estimated EPS was $2.78/share. The difference between the actual and Estimated EPS is $-0.06. This shows a surprise factor of -2.2 percent.

The company has YTD performance of -3.02 percent. Beta for Penn Virginia Corporation stands at 0 while its ATR (average true range) is 1.89. The company has Weekly Volatility of 3.19%% and Monthly Volatility of 3.24%%.

Penn Virginia Corporation has distance from 20-day Simple Moving Average (SMA20) of -1.05%, Distance from 50-Day Simple Moving Average of -4.91 percent and Distance from 200-Day Simple Moving Average of -24.51%.

The Company currently has ROA (Return on Assets) of 1.6 percent, Return on Equity (ROE) of 5.7 Percent and Return on Investment (ROI) of 29.4% with Gross margin of 81.5 percent and Operating & Profit margin of 47.3% and 3.6% respectively.

SHARE